Search Results

There are 4107 results for: content related to: Multiple effects of silymarin on the hepatitis C virus lifecycle

  1. Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis

    Molecular Carcinogenesis

    Volume 54, Issue 11, November 2015, Pages: 1328–1339, Mudit Vaid, Tripti Singh, Ram Prasad and Santosh K. Katiyar

    Version of Record online : 30 AUG 2014, DOI: 10.1002/mc.22208

  2. Silymarin attenuates paraquat-induced lung injury via Nrf2-mediated pathway in vivo and in vitro

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 9, September 2015, Pages: 988–998, Feng Zhao, Danyang Shi, Tiegang Li, Lizhuo Li and Min Zhao

    Version of Record online : 25 AUG 2015, DOI: 10.1111/1440-1681.12448

  3. You have free access to this content
    Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection


    Volume 57, Issue 3, March 2013, Pages: 1262–1271, Stephen J. Polyak, Peter Ferenci and Jean-Michel Pawlotsky

    Version of Record online : 28 FEB 2013, DOI: 10.1002/hep.26179

  4. You have free access to this content
    Milk thistle in liver diseases: past, present, future

    Phytotherapy Research

    Volume 24, Issue 10, October 2010, Pages: 1423–1432, Ludovico Abenavoli, Raffaele Capasso, Natasa Milic and Francesco Capasso

    Version of Record online : 7 JUN 2010, DOI: 10.1002/ptr.3207

  5. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate–caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1α expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotion

    Molecular Carcinogenesis

    Volume 26, Issue 4, December 1999, Pages: 321–333, Jifu Zhao, Yogesh Sharma and Rajesh Agarwal

    Version of Record online : 22 NOV 1999, DOI: 10.1002/(SICI)1098-2744(199912)26:4<321::AID-MC11>3.0.CO;2-9

  6. Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 434–449, Dr Roy L. Hawke, Dr Sarah J. Schrieber, Dr Tedi A. Soule, Dr Zhiming Wen, Dr Philip C. Smith, Dr K. Rajender Reddy, Dr Abdus S. Wahed, Dr Steven H. Belle, Dr Nezam H. Afdhal, Dr Victor J. Navarro, Dr Josh Berman, Dr Qi-Ying Liu, Dr Edward Doo, Dr Michael W. Fried and The SyNCH Trial Group

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009347475

  7. Silymarin potentiates the antinociceptive effect of morphine in mice

    Phytotherapy Research

    Volume 25, Issue 2, February 2011, Pages: 250–255, Hassan Malekinejad, Maysam Taheri-Broujerdi, Masumeh Moradi and Seyed-Hamed Tabatabaie

    Version of Record online : 16 JUL 2010, DOI: 10.1002/ptr.3251

  8. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

    Phytotherapy Research

    Volume 29, Issue 7, July 2015, Pages: 1046–1053, Foroud Shahbazi, Sanambar Sadighi, Simin Dashti-Khavidaki, Farhad Shahi, Mehrzad Mirzania, Alireza Abdollahi and Mohammad-Hossein Ghahremani

    Version of Record online : 7 APR 2015, DOI: 10.1002/ptr.5345

  9. You have free access to this content
    Silymarin use and liver disease progression in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis trial

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 1, January 2011, Pages: 127–137, N. D. Freedman, T. M. Curto, C. Morishima, L. B. Seeff, Z. D. Goodman, E. C. Wright, R. Sinha, J. E. Everhart and the HALT-C Trial Group

    Version of Record online : 2 NOV 2010, DOI: 10.1111/j.1365-2036.2010.04503.x

  10. Silymarin treatment of viral hepatitis: a systematic review

    Journal of Viral Hepatitis

    Volume 12, Issue 6, November 2005, Pages: 559–567, K. É. Mayer, R. P. Myers and S. S. Lee

    Version of Record online : 29 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00636.x

  11. The flavonolignan-silymarin protects enzymatic, hematological, and immune system against γ-radiation-induced toxicity

    Environmental Toxicology

    Volume 31, Issue 6, June 2016, Pages: 641–654, Manish Adhikari and Rajesh Arora

    Version of Record online : 20 NOV 2014, DOI: 10.1002/tox.22076

  12. You have free access to this content
    Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats

    International Journal of Cancer

    Volume 101, Issue 5, 10 October 2002, Pages: 461–468, Hiroyuki Kohno, Takuji Tanaka, Kunihiro Kawabata, Yoshinobu Hirose, Shigeyuki Sugie, Hiroyuki Tsuda and Hideki Mori

    Version of Record online : 13 AUG 2002, DOI: 10.1002/ijc.10625

  13. Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells

    Cell Proliferation

    Volume 42, Issue 2, April 2009, Pages: 229–240, G. Ramakrishnan, L. Lo Muzio, C. M. Elinos-Báez, S. Jagan, T. A. Augustine, S. Kamaraj, P. Anandakumar and T. Devaki

    Version of Record online : 13 MAR 2009, DOI: 10.1111/j.1365-2184.2008.00581.x

  14. Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action

    CNS Neuroscience & Therapeutics

    Volume 19, Issue 11, November 2013, Pages: 847–853, Anupom Borah, Rajib Paul, Sabanum Choudhury, Amarendranath Choudhury, Bornalee Bhuyan, Anupam Das Talukdar, Manabendra Dutta Choudhury and Kochupurackal P Mohanakumar

    Version of Record online : 14 OCT 2013, DOI: 10.1111/cns.12175


    Journal of Food Biochemistry

    Volume 36, Issue 3, June 2012, Pages: 369–377, CHUNG-HSI CHOU, YI-CHEN CHEN, MENG-CHIEH HSU, WEI-LUN TSAI, CHIA-YI CHANG and CHIH-HSIEN CHIU

    Version of Record online : 21 DEC 2011, DOI: 10.1111/j.1745-4514.2011.00543.x

  16. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis

    Journal of the Science of Food and Agriculture

    Volume 92, Issue 7, May 2012, Pages: 1441–1447, I-Shu Chen, Yi-Chen Chen, Chung-Hsi Chou, Ruei-Feng Chuang, Lee-Yan Sheen and Chih-Hsien Chiu

    Version of Record online : 18 NOV 2011, DOI: 10.1002/jsfa.4723

  17. Anti- and pro-mutagenic effects of silymarin in the ames bacterial reverse mutation assay

    Phytotherapy Research

    Volume 23, Issue 10, October 2009, Pages: 1378–1384, Sampath Kaleeswaran, Padmanabhan Sriram, Daivasigamani Prabhu, Chinnathambi, Vijayakumar and Lalgudi Narayanan Mathuram

    Version of Record online : 10 MAR 2009, DOI: 10.1002/ptr.2772

  18. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine

    European Journal of Haematology

    Volume 90, Issue 3, March 2013, Pages: 202–209, Behjat Moayedi, Marjan Gharagozloo, Nafiseh Esmaeil, Mohammad R. Maracy, Hamid Hoorfar and Mohsen Jalaeikar

    Version of Record online : 20 JAN 2013, DOI: 10.1111/ejh.12061

  19. The effect of silymarin and gamma radiation on nucleic acids in rat organs

    Journal of Pharmacy and Pharmacology

    Volume 45, Issue 10, October 1993, Pages: 910–912, H. Haková and E. Mišúrová

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1993.tb05619.x

  20. Silymarin Inhibits Cervical Cancer Cell Through an Increase of Phosphatase and Tensin Homolog

    Phytotherapy Research

    Volume 26, Issue 5, May 2012, Pages: 709–715, Hann-Chin Yu, Li-Jen Chen, Kai-Chun Cheng, Ying-Xiao Li, Ching-Hua Yeh and Juei-Tang Cheng

    Version of Record online : 20 OCT 2011, DOI: 10.1002/ptr.3618